Bank Central Asia BBCA IJ - Buy - Solid YTD Jul-24 results
BBCA’s bank-only Jul-24 earnings of IDR4.9tr (+1% m-m / +17% y-y) brings YTD Jul-24 headline profit to
BRIS has released its YTD Jul-24 results, with headline profit of IDR3.9tn (+21% y-y) accounting for 62% of our FY24F profit estimate of IDR6.3tn. At the operating level, the bank reported YTD net financing income of IDR10.3tn (+3% y-y) and PPOP of IDR6.3tn (+4% y-y). The soft y-y financing income growth can be attributed to lack of asset yields’ repricing (which stood at 7.3% or -20bp y-y), while funding expenses increased (rising to 2.6% or +30bp y-y). This translates to YTD-24 annualized NIM of 5.1% (-50bp y-y). Further, while we see limited scope for Indonesia banks (including BRIS) to reprice their lending rates upward, we see early encouraging signs as funding expenses appear to have stabilized (and for BRIS, it is at around 2.6% — a slight decline from the peak of 2.8% in Mar-24). Going into 4Q24 we see opportunities for funding costs to decline as we expect BI to reduce its benchmark rates as well as reducing its SRBI issuances (thereby potentially improving system liquidity). Within the Indonesia banking sector, BRIS haa a relatively large portion of fixed-yield earnings assets than other banks. Post the results, we retain our Buy rating for the stock, primarily reflecting the bank’s dominant position in Indonesia’s under-penetrated Syariah-based banking.
In this report, we take a deep-dive into the bank's monthly results trends. Monthly results can be volatile, which makes analyzing the trends challenging. For instance, at the end of the quarter, the bank would report a jump in financing income as some borrowers pay their financing expenses (i.e. financing income to BRIS) on a quarterly basis. Consequently, when analyzing monthly net financing income (NFI) of IDR1.5tn (for Jul-24-only), it is below Mar-24 and Jun-24-only NFIs. Still, on a y-y basis, Jul-24-only NFI was up 5% y-y primarily due to gross financing increase of ~14% y-y (this helped to offset lower NFM of 50bp y-y to 5.1% in YTD Jul-24). On asset qualities, according to management, the bank has implemented a more stringent underwriting procedure, and hence we expect asset qualy to improve. Thus, it should not come as a surprise that the bank’s credit costs hovered around 50bp in Jul-24, bringing YTD figure to 0.9% (-60bp y-y). This brings reserves for financing losses (i.e., LLR) at 3.9% (-10bp m-m / -50bp y-y). This is one of the lowest among the Indonesia banks under our coverage. However, the bank has large financing exposure to payroll financing which has limited risk in nature. We do not think BRIS can afford to continue recording lower LLR in the long term as the current LLR is at around the pre-merger level (2021, when BNI Syariah and Bank Syariah Mandiri officially merged with BRIS)
On balance sheet, the bank reported gross financing growth of 14% y-y, with financing deposits up 11%, resulting in a financing-to-funding ratio (i.e., LDR) of 85.2% (-40bp m-m / -100bp y-y). In Jul-24, current account was the main growth driver (+7% m-m / +41% y-y), followed by savings account (flat m-m / +15% y-y) and time deposits (-2% m-m / +6% y-y).
Valuation and risks
We derive our TP of IDR3,100 using DuPont methodology, with key parameters as below: a risk-free rate of 6.5%, an equity risk premium of 7.8%, beta of 1.2x, and a CAR-adjusted ROAE of 18.0%. We also use FY24F book as a reference in deriving our TP. Our TP implies a FY24F P/B of 3.2x and a FY24F P/E of 22.6x. The stock currently trades at a FY24F P/B of 2.4x and FY24F P/E of 16.7x. Risks are: worsening macroeconomic trends, unfavorable regulatory changes, tighter liquidity competition that could increase funding costs, worsening credit quality that could raise credit costs, material management changes, and/or persistently high opex.
INVESTMENT RATINGS
A rating of ‘Buy’, indicates that the analyst expects the stock to outperform the Benchmark over the next 12 months. A rating of ‘Neutral’, indicates that the analyst expects the stock to perform in line with the Benchmark over the next 12 months. A rating of ‘Reduce’, indicates that the analyst expects the stock to underperform the Benchmark over the next 12 months. A rating of ‘Suspended’, indicates that the rating, target price, and estimates have been suspended temporarily to comply with applicable regulations and/or firm policies. Securities and/or companies that are labelled as ‘Not Rated’ or ‘No Rating’ are not in regular research coverage. Benchmark is Indonesia Composite Index (‘IDX Composite’). A ‘Target Price’, if discussed, indicates the analyst’s forecast for the share price with a 12-month time horizon, reflecting in part of the analyst’s estimates for the company’s earnings, and may be impeded by general market and macroeconomic trends, and by other risks related to the company or the market in general.
GENERAL DISCLOSURE/DISCLAIMER
This report is prepared by PT Verdhana Sekuritas Indonesia (“PTVSI”) a securities company registered in Indonesia, supervised by Indonesia Financial Services Authority (OJK) and a member of the Indonesia Stock Exchange (IDX).
This report is intended for client of PTVSI only and no part of this document may be (i) copied, photocopied or duplicated in any form or by any means or (ii) redistributed without the prior written consent of PTVSI.
The research set out in this report is based on information obtained from sources believed to be reliable, but PTVSI do not make any representation or warranty as to its accuracy, completeness or correctness. The information in this report is subject to change without notice, its accuracy is not guaranteed, it may be incomplete or condensed and it may not contain all material information concerning the company (or companies) referred to in this report. Any information, valuations, opinions, estimates, forecasts, ratings or targets herein constitutes a judgment as of the date of this report is published, and there is no assurance that future results or events will be consistent.
This report is not to be construed as an offer or a solicitation of an offer to buy or sell any securities or financial products. PTVSI and its associates, its directors, and/or its employees may from time to time have interests in the securities mentioned in this report or it may or will engage in any securities transaction or other capital market services for the company (companies) mentioned herein.
ANALYST CERTIFICATION
The research analyst primarily responsible for the content of this report and certifies that the views about the companies including their securities expressed in this report accurately reflect his/her personal views. The analyst also certifies that no part of his/her compensation was, is, or will be, directly, or indirectly, related to specific recommendations or views expressed in this report.
RESTRICTIONS ON DISTRIBUTION
By accepting this report, the recipient hereof represents and warrants that you are entitled to receive such report in accordance with the restrictions and agrees to be bound by the limitations contained herein. Neither this report nor any copy hereof may be distributed except in compliance with applicable Indonesian capital market laws and regulations.
Rating Remains | Buy |
Target price Remains | IDR 3,100 |
Closing price 2 September 2024 | IDR 2,610 |
Nicholas Santoso (nicholas.santoso@verdhana.id)
Erwin Wijaya (erwin.wijaya@verdhana.id)